Literature DB >> 10590408

Diagnostic criteria for demyelinating polyneuropathy associated with monoclonal gammopathy.

N C Notermans1, H Franssen, M Eurelings, Y Van der Graaf, J H Wokke.   

Abstract

In order to define diagnostic criteria for the demyelinating polyneuropathy associated with monoclonal gammopathy of undetermined significance (MGUS), we compared 30 patients with idiopathic chronic inflammatory demyelinating polyneuropathy (CIDP) without a monoclonal gammopathy, with 29 patients with polyneuropathy associated with MGUS. All 59 patients fulfilled research criteria for CIDP. In the patients with MGUS, sensory symptoms and signs predominated, there was usually no cranial nerve involvement, and the neuropathy was symmetrical with a slowly progressive course. On electrophysiological examination, an abnormal median nerve sensory action potential in combination with a normal sural nerve action potential (AMNS) was not found. In idiopathic CIDP patients, a preceding infection was frequent, motor features predominated, there was often cranial nerve involvement, the neuropathy could be asymmetrical, and AMNS was frequently found. Diagnostic criteria for demyelinating polyneuropathy associated with MGUS are presented. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10590408     DOI: 10.1002/(sici)1097-4598(200001)23:1<73::aid-mus9>3.0.co;2-5

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  6 in total

1.  A case of anti-myelin-associated glycoprotein polyneuropathy and multiple sclerosis: one disease instead of two?

Authors:  Stefano Sotgiu; Alessandra Giua; Maria R Murrighile; Renato Ortu
Journal:  BMJ Case Rep       Date:  2009-02-20

Review 2.  Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Association With Concomitant Diseases: Identification and Management.

Authors:  Yan Chen; Xiangqi Tang
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

Review 3.  Multifocal motor neuropathy, multifocal acquired demyelinating sensory and motor neuropathy, and other chronic acquired demyelinating polyneuropathy variants.

Authors:  Mazen M Dimachkie; Richard J Barohn; Jonathan Katz
Journal:  Neurol Clin       Date:  2013-02-16       Impact factor: 3.806

Review 4.  Treatment for IgG and IgA paraproteinaemic neuropathy.

Authors:  Abraham C J Stork; Michael P T Lunn; Eduardo Nobile-Orazio; Nicolette C Notermans
Journal:  Cochrane Database Syst Rev       Date:  2015-03-24

5.  Neuropathy associated with immunoglobulin M monoclonal gammopathy: A combined sonographic and nerve conduction study.

Authors:  H Stephan Goedee; Nicolette C Notermans; Leo H Visser; Jan-Thies H van Asseldonk; Hessel Franssen; Alexander F J E Vrancken; Stavros Nikolakopoulos; Leonard H van den Berg; W Ludo van der Pol
Journal:  Muscle Nerve       Date:  2019-07-24       Impact factor: 3.217

6.  Functioning and quality of life in patients with neuropathy associated with anti-MAG antibodies.

Authors:  Yuri M Falzone; Marta Campagnolo; Mariangela Bianco; Patrizia Dacci; Daniele Martinelli; Marta Ruiz; Silvia Bocci; Federica Cerri; Angelo Quattrini; Giancarlo Comi; Luana Benedetti; Fabio Giannini; Giuseppe Lauria; Eduardo Nobile-Orazio; Chiara Briani; Raffaella Fazio; Nilo Riva
Journal:  J Neurol       Date:  2018-10-10       Impact factor: 4.849

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.